Secondary Structural Model of Human MALAT1 Reveals Multiple Structure-Function Relationships.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
09 Nov 2019
Historique:
received: 24 10 2019
accepted: 07 11 2019
entrez: 14 11 2019
pubmed: 14 11 2019
medline: 4 4 2020
Statut: epublish

Résumé

Human metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) is an abundant nuclear-localized long noncoding RNA (lncRNA) that has significant roles in cancer. While the interacting partners and evolutionary sequence conservation of MALAT1 have been examined, much of the structure of MALAT1 is unknown. Here, we propose a hypothetical secondary structural model for 8425 nucleotides of human MALAT1 using three experimental datasets that probed RNA structures in vitro and in various human cell lines. Our model indicates that approximately half of human MALAT1 is structured, forming 194 helices, 13 pseudoknots, five structured tetraloops, nine structured internal loops, and 13 intramolecular long-range interactions that give rise to several multiway junctions. Evolutionary conservation and covariation analyses support 153 of 194 helices in 51 mammalian MALAT1 homologs and 42 of 194 helices in 53 vertebrate MALAT1 homologs, thereby identifying an evolutionarily conserved core that likely has important functional roles in mammals and vertebrates. Data mining revealed that RNA modifications, somatic cancer-associated mutations, and single-nucleotide polymorphisms may induce structural rearrangements that sequester or expose binding sites for several cancer-associated microRNAs. Our findings reveal new mechanistic leads into the roles of MALAT1 by identifying several intriguing structure-function relationships in which the dynamic structure of MALAT1 underlies its biological functions.

Identifiants

pubmed: 31717552
pii: ijms20225610
doi: 10.3390/ijms20225610
pmc: PMC6888369
pii:
doi:

Substances chimiques

MALAT1 long non-coding RNA, human 0
RNA, Long Noncoding 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Henry Luce Foundation
ID : Clare Boothe Luce Program
Organisme : University of Notre Dame
ID : Start-up funds
Organisme : University of California, Santa Barbara
ID : Academic Senate for Intramural Research Grants

Références

J Mol Biol. 2019 Apr 5;431(8):1592-1603
pubmed: 30890332
Biochem Biophys Res Commun. 2015 Sep 18;465(2):293-8
pubmed: 26265046
Nucleic Acids Res. 2008 Jan;36(Database issue):D154-8
pubmed: 17991681
PLoS Genet. 2015 Dec 08;11(12):e1005668
pubmed: 26646615
Nat Methods. 2017 Jan;14(1):45-48
pubmed: 27819659
Nat Commun. 2018 Oct 18;9(1):4328
pubmed: 30337527
RNA. 2013 Dec;19(12):1848-56
pubmed: 24141618
Nucleic Acids Res. 2012 Jun;40(11):5023-33
pubmed: 22344696
BMC Bioinformatics. 2011 Jan 04;12:3
pubmed: 21205310
Nucleic Acids Res. 2019 Jan 8;47(D1):D155-D162
pubmed: 30423142
J Proteome Res. 2018 Sep 7;17(9):3022-3038
pubmed: 29972301
Nat Methods. 2015 Aug;12(8):767-72
pubmed: 26121403
Mol Cell. 2011 Aug 5;43(3):327-39
pubmed: 21723170
Nucleic Acids Res. 2012 Jun;40(11):5034-51
pubmed: 22362738
Nature. 2017 Nov 9;551(7679):251-255
pubmed: 29072297
N Engl J Med. 2016 Sep 22;375(12):1109-12
pubmed: 27653561
Nucleic Acids Res. 2013 Sep;41(17):8220-36
pubmed: 23847102
Oncol Lett. 2018 May;15(5):7571-7578
pubmed: 29725462
Algorithms Mol Biol. 2011 Nov 24;6:26
pubmed: 22115189
Cell. 2014 Sep 25;159(1):188-199
pubmed: 25259926
J Biol Chem. 2015 Feb 13;290(7):3925-35
pubmed: 25538231
Mol Syst Biol. 2011 Oct 11;7:539
pubmed: 21988835
Front Physiol. 2018 Aug 24;9:1201
pubmed: 30197605
Nucleic Acids Res. 2018 Apr 20;46(7):3742-3752
pubmed: 29394378
Nat Commun. 2018 Jul 17;9(1):2761
pubmed: 30018356
Cell Mol Biol Lett. 2019 Jul 27;24:50
pubmed: 31372165
Nucleic Acids Res. 2018 Jul 2;46(W1):W537-W544
pubmed: 29790989
Mol Cell. 2014 Sep 4;55(5):791-802
pubmed: 25155612
Nat Rev Genet. 2018 Sep;19(9):535-548
pubmed: 29795125
BMC Cancer. 2017 Mar 3;17(1):167
pubmed: 28253859
Genes Dev. 2016 Jan 1;30(1):34-51
pubmed: 26701265
Oncotarget. 2018 Apr 20;9(30):21580-21612
pubmed: 29765562
Mol Cancer. 2017 Nov 21;16(1):174
pubmed: 29162158
Sci Rep. 2017 Dec 8;7(1):17269
pubmed: 29222504
Mol Cell. 2016 May 19;62(4):603-17
pubmed: 27184079
Cell. 2011 Dec 23;147(7):1537-50
pubmed: 22196729
Cancer Res. 2013 Feb 1;73(3):1180-9
pubmed: 23243023
Nat Struct Mol Biol. 2014 Jul;21(7):633-40
pubmed: 24952594
Nucleic Acids Res. 2017 Jun 2;45(10):6051-6063
pubmed: 28334903
Nature. 2014 Jan 30;505(7485):701-5
pubmed: 24336214
Curr Protoc Chem Biol. 2012 Dec 1;4(4):275-97
pubmed: 23788555
Nucleic Acids Res. 2014 Jan;42(Database issue):D92-7
pubmed: 24297251
Cell Death Dis. 2016 Sep 01;7(9):e2352
pubmed: 27584791
Nature. 2014 Jan 30;505(7485):706-9
pubmed: 24476892
J Cell Mol Med. 2016 Dec;20(12):2299-2308
pubmed: 27420766
Cell. 2008 Nov 28;135(5):919-32
pubmed: 19041754
Nucleic Acids Res. 2010 Jan;38(Database issue):D280-2
pubmed: 19880381
BMC Genomics. 2007 Feb 01;8:39
pubmed: 17270048
Mol Cell. 2015 Apr 16;58(2):353-61
pubmed: 25866246
Cancer Res. 2015 Apr 1;75(7):1322-31
pubmed: 25600645
Sci Rep. 2017 Jul 12;7(1):5186
pubmed: 28701723
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W59-64
pubmed: 22492627
Oncotarget. 2017 Dec 14;9(7):7501-7512
pubmed: 29484127
Genome Res. 2002 Jun;12(6):996-1006
pubmed: 12045153
Nat Methods. 2017 Jul;14(7):695-698
pubmed: 28504680
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Sci Rep. 2013;3:2535
pubmed: 23985560
Cell Rep. 2017 May 23;19(8):1723-1738
pubmed: 28538188
Proc Natl Acad Sci U S A. 2016 Dec 6;113(49):14013-14018
pubmed: 27872311
J Cell Biochem. 2019 Apr;120(4):5542-5550
pubmed: 30362606
J Neurochem. 2016 Aug;138 Suppl 1:95-111
pubmed: 27015757
Med Sci Monit. 2016 Feb 02;22:356-61
pubmed: 26835790
J Hematol Oncol. 2018 May 8;11(1):63
pubmed: 29739426
Mol Cell. 2019 Jun 20;74(6):1304-1316.e8
pubmed: 31031084
Nucleic Acids Res. 2018 Jan 4;46(D1):D139-D145
pubmed: 29036329
Cancer Biol Ther. 2017 May 4;18(5):269-276
pubmed: 28453394
Cell. 2016 Jun 2;165(6):1416-1427
pubmed: 27259150
Bioinformatics. 2009 Aug 1;25(15):1974-5
pubmed: 19398448
Mol Cell. 2010 Sep 24;39(6):925-38
pubmed: 20797886
Cell. 2016 May 19;165(5):1267-1279
pubmed: 27180905
Genome Biol. 2007;8(2):R24
pubmed: 17324271
Nucleic Acids Res. 2017 Sep 29;45(17):9947-9959
pubmed: 28973437
Bioinformatics. 2013 Nov 15;29(22):2933-5
pubmed: 24008419
Nature. 2015 Feb 26;518(7540):560-4
pubmed: 25719671
Methods Mol Biol. 2018;1649:59-84
pubmed: 29130190
Int J Mol Sci. 2017 Nov 10;18(11):
pubmed: 29125541
Oncol Rep. 2017 Oct;38(4):2182-2188
pubmed: 28849236
Oncotarget. 2017 Sep 6;8(63):106648-106660
pubmed: 29290978

Auteurs

Phillip J McCown (PJ)

Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.

Matthew C Wang (MC)

Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.

Luc Jaeger (L)

Department of Chemistry and Biochemistry, Biomolecular Science and Engineering Program, University of California at Santa Barbara, Santa Barbara, CA 93106, USA.

Jessica A Brown (JA)

Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, IN 46556, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH